McAdam LLC’s MetLife MET Stock Holding History

McAdam LLC’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-469	Closed	-$22K	–	399
2018 Q3	$22K	Hold	469	–	–	0.01%	244
2018 Q2	$20K	Hold	469	–	–	0.01%	244
2018 Q1	$22K	Buy	+469	New	+$22.8K	0.01%	229

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

McAdam LLC's MET Position: Q4 2018 in Review

McAdam LLC sold out of MetLife (MET) in Q4 2018, closing a stake of 469 shares — an estimated $22K sold.

McAdam LLC first reported a position in MET in Q1 2018 and held it in 3 quarters. The position peaked at $22K in Q3 2018. 1,008 funds tracked by Wall St. Rank hold MET as of Q4 2018.

McAdam LLC reported no remaining MetLife position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 469 MetLife shares in Q4 2018, an estimated $22K.
McAdam LLC first reported a position in MetLife in Q1 2018 and held it in 3 quarters.
McAdam LLC's MetLife position peaked at $22K in Q3 2018.
1,008 funds tracked by Wall St. Rank held MetLife as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.